Aymeric Seve

14, Avenue De L'hôpital, Orléans Cedex 2
Orleans, 45067, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications

Fully injectable antiretroviral multitherapy to overcome decades of virological failure in three women with hiv-1 and non-adherent to oral drugs.

Fully injectable antiretroviral multitherapy to overcome decades of virological failure in three women with hiv-1 and non-adherent to oral drugs.

Journal: International journal of antimicrobial agents
Published: February 08, 2024

Prone position versus usual care in hypoxemic COVID-19 patients in medical wards: a randomised controlled trial.

Prone position versus usual care in hypoxemic COVID-19 patients in medical wards: a randomised controlled trial.

Journal: Critical care (London, England)
Published: March 15, 2023

Longitudinal analysis of serum neutralization of SARS-CoV-2 Omicron BA.2, BA.4, and BA.5 in patients receiving monoclonal antibodies.

Longitudinal analysis of serum neutralization of SARS-CoV-2 Omicron BA.2, BA.4, and BA.5 in patients receiving monoclonal antibodies.

Journal: Cell reports. Medicine
Published: August 16, 2022

Duration of BA.5 neutralization in sera and nasal swabs from SARS-CoV-2 vaccinated individuals, with or without omicron breakthrough infection.

Duration of BA.5 neutralization in sera and nasal swabs from SARS-CoV-2 vaccinated individuals, with or without omicron breakthrough infection.

Journal: Med (New York, N.Y.)
Published: August 10, 2022

Does awake prone positioning prevent the use of mechanical respiratory support or death in COVID-19 patients on standard oxygen therapy hospitalised in general wards? A multicentre randomised controlled trial: the PROVID-19 protocol.

Does awake prone positioning prevent the use of mechanical respiratory support or death in COVID-19 patients on standard oxygen therapy hospitalised in general wards? A multicentre randomised controlled trial: the PROVID-19 protocol.

Journal: BMJ open
Published: July 08, 2022

Serum neutralization of SARS-CoV-2 Omicron sublineages BA.1 and BA.2 in patients receiving monoclonal antibodies.

Serum neutralization of SARS-CoV-2 Omicron sublineages BA.1 and BA.2 in patients receiving monoclonal antibodies.

Journal: Nature medicine
Published: March 06, 2022

Fusogenicity and neutralization sensitivity of the SARS-CoV-2 Delta sublineage AY.4.2.

Fusogenicity and neutralization sensitivity of the SARS-CoV-2 Delta sublineage AY.4.2.

Journal: EBioMedicine
Published: January 06, 2022

Considerable escape of SARS-CoV-2 Omicron to antibody neutralization.

Considerable escape of SARS-CoV-2 Omicron to antibody neutralization.

Journal: Nature
Published: December 10, 2021

Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization.

Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization.

Journal: Nature
Published: May 26, 2021

Effect of Tenofovir Disoproxil Fumarate and Emtricitabine on nasopharyngeal SARS-CoV-2 viral load burden amongst outpatients with COVID-19: A pilot, randomized, open-label phase 2 trial.

Effect of Tenofovir Disoproxil Fumarate and Emtricitabine on nasopharyngeal SARS-CoV-2 viral load burden amongst outpatients with COVID-19: A pilot, randomized, open-label phase 2 trial.

Journal: EClinicalMedicine
Published: May 18, 2021

Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies.

Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies.

Journal: Nature medicine
Published: February 12, 2021

High performance of a novel antigen detection test on nasopharyngeal specimens for diagnosing SARS-CoV-2 infection.

High performance of a novel antigen detection test on nasopharyngeal specimens for diagnosing SARS-CoV-2 infection.

Journal: Journal of medical virology
Published: January 04, 2021
Showing 1-12 of 20

Last Updated: 09/26/2026